Back to DSGN

Elmind Capital, LP → DSGN

Elmind Capital, LP DSGN Position History

Design Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$1.4M
Q3 2026
Peak value
$2.2M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$2M
Q1 2026$2.2M
Q2 2026$1.6M
Q3 2026$1.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1.4M107.9K——
Q2 2026$1.6M107.9K——
Q1 2026$2.2M207.9K——
Q4 2025$2M207.9K——

Other funds holding DSGN

Other Elmind Capital, LP positions

COGT

COGENT BIOSCIENCES INC

$45.3M
COGT

COGENT BIOSCIENCES INC

$45.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$43.3M
COGT

COGENT BIOSCIENCES INC

$41.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$40.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$39M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36.8M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36M